Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification-Reference-Cited by-同舟云学术

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

Published:2017-07-28 Issue:11 Volume:30 Page:1516-1526
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Chen Meixuan^ORCID,Andreozzi Mariacarla,Pockaj Barbara,Barrett Michael T,Ocal Idris Tolgay,McCullough Ann E,Linnaus Maria E,Chang James M,Yearley Jennifer H,Annamalai Lakshmanan,Anderson Karen S

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201786.pdf

Reference53 articles.

1. Hao Y, Chapuy B, Monti S et al. Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo. Clin Cancer Res 2014;20:2674–2683.

2. Barrett MT, Anderson KS, Lenkiewicz E et al. Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer. Oncotarget 2015;6:26483–26493.

3. Wu J, Liu S, Liu G et al. Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene 2012;31:333–341.

4. Balko JM, Schwarz LJ, Luo N et al. Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence. Sci Transl Med 2016;8:334ra353.

5. Roemer MG, Advani RH, Ligon AH et al. PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol 2016;34:2690–2697.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-06

2. Mapping cancer biology in space: applications and perspectives on spatial omics for oncology;Molecular Cancer;2024-01-30

3. Rapid visualization of PD-L1 expression level in glioblastoma immune microenvironment via machine learning cascade-based Raman histopathology;Journal of Advanced Research;2023-12

4. Docosahexaenoic acid reverses PD-L1-mediated immune suppression by accelerating its ubiquitin-proteasome degradation;The Journal of Nutritional Biochemistry;2023-02

5. A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids;Frontiers in Oncology;2021-10-14